DERMATA THERAPEUTICS INC (DRMA) Stock Earnings & Estimates
NASDAQ:DRMA - US2498454055 - Common Stock
5.83 USD
+0.35 (+6.39%)
6.267 USD
+0.44 (+7.5%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | |||||||
| EBITDA YoY % growth | -4.469M | -3.173M 29.01% | -7.857M -147.65% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -4.471M | -3.173M 29.03% | -7.857M -147.63% | -9.675M -23.13% | -8.042M 16.88% | -12.513M -55.60% | N/A 16.10% | N/A -60.96% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -220.80 96.76% | -54.75 75.20% | -33.87 38.14% | N/A 76.63% | N/A 19.72% |
All data in USD
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -2.45 -20.00% | -4.18 79.70% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -2.051M 36.41% | -4.09M -27.81% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.66 60.29% | -2.96 | 1.30 | 43.88% |
| Q1 2025 Q2Q % growth | -4.50 36.17% | -4.59 | 0.09 | 1.96% |
| Q4 2024 Q2Q % growth | -20.60 -553.97% | -15.30 | -5.30 | -34.64% |
| Q3 2024 Q2Q % growth | -2.04 74.81% | -2.69 | 0.65 | 24.24% |
| Q2 2024 Q2Q % growth | -4.18 55.77% | -3.87 | -0.31 | -8.13% |
| Q1 2024 Q2Q % growth | -7.05 79.30% | -5.51 | -1.54 | -28.00% |
| Q4 2023 Q2Q % growth | -3.15 91.25% | -11.93 | 8.78 | 73.60% |
| Q3 2023 Q2Q % growth | -8.10 83.13% | -9.64 | 1.54 | 15.97% |
| Q2 2023 Q2Q % growth | -9.45 83.59% | -14.08 | 4.63 | 32.86% |
| Q1 2023 Q2Q % growth | -34.05 57.01% | -40.55 | 6.50 | 16.02% |
| Q4 2022 Q2Q % growth | -36.00 42.31% | -48.96 | 12.96 | 26.47% |
| Q3 2022 Q2Q % growth | -48.00 76.74% | -53.86 | 5.86 | 10.87% |
| Q2 2022 Q2Q % growth | -57.60 65.71% | -78.34 | 20.74 | 26.47% |
| Q1 2022 Q2Q % growth | -79.20 | -97.92 | 18.72 | 19.12% |
| Q4 2021 Q2Q % growth | -62.40 | -86.90 | 24.50 | 28.20% |
| Q3 2021 Q2Q % growth | -206.40 | -112.61 | -93.79 | -83.29% |
| Q2 2021 Q2Q % growth | -168.00 | -345.17 | 177.17 | 51.33% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -900% | -650% | -466.42% | -676% |
| Revenue | N/A | N/A | N/A | N/A |